ResearcherUniversity of MinnesotaNo recent work listed
Rohit Chugh
Matched on OpenAlex author ID A5111971782. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2012: 1 paper · 2013: 1 paper · 2014: 3 papers · 2015: 1 paper · 2016: 1 paper
Papers 7
- A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies. Co-author DOI 10.1007/s11605-015-2985-y↗
- CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. Co-author DOI 10.18632/oncotarget.3228↗
- Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway. Co-author DOI 10.1016/j.canlet.2014.03.016↗
- Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells. Co-author DOI 10.1152/ajpgi.00466.2013↗
- CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide. Co-author DOI 10.1158/1078-0432.ccr-13-2947↗
- Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1. Co-author DOI 10.1074/jbc.m113.500983↗
- A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer. Co-author DOI 10.1126/scitranslmed.3004334↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sulagna Banerjee · 7 shared papers, 2012–2016 · strength 0.32
- Paper CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. DOI 10.18632/oncotarget.3228↗
- Paper A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation… DOI 10.1007/s11605-015-2985-y↗
- Paper Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway. DOI 10.1016/j.canlet.2014.03.016↗
- Ashok Kumar Saluja · 7 shared papers, 2012–2016 · strength 0.32
- Paper CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. DOI 10.18632/oncotarget.3228↗
- Paper A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation… DOI 10.1007/s11605-015-2985-y↗
- Paper Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway. DOI 10.1016/j.canlet.2014.03.016↗
- Vikas Dudeja · 7 shared papers, 2012–2016 · strength 0.32
- Paper CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. DOI 10.18632/oncotarget.3228↗
- Paper A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation… DOI 10.1007/s11605-015-2985-y↗
- Paper Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway. DOI 10.1016/j.canlet.2014.03.016↗
- Selwyn Maurice Vickers · 6 shared papers, 2012–2015 · strength 0.26
- Paper CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. DOI 10.18632/oncotarget.3228↗
- Paper Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the death receptor pathway. DOI 10.1016/j.canlet.2014.03.016↗
- Paper CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide. DOI 10.1158/1078-0432.ccr-13-2947↗
- Alice Nomura · 3 shared papers, 2014–2016 · strength 0.16
- Paper CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. DOI 10.18632/oncotarget.3228↗
- Paper A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation… DOI 10.1007/s11605-015-2985-y↗
- Paper CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide. DOI 10.1158/1078-0432.ccr-13-2947↗
- Masato Yamamoto · 2 shared papers, 2014–2015 · strength 0.10
- Sundaram Ramakrishnan · 1 shared paper, 2016 · strength 0.05
- Bhuwan Giri · 1 shared paper, 2016 · strength 0.05
- Shrey Modi · 1 shared paper, 2016 · strength 0.05
- Kaustav Majumder · 1 shared paper, 2016 · strength 0.05
- Zhiyu Chen · 1 shared paper, 2014 · strength 0.05
- Nameeta R. Mujumdar · 1 shared paper, 2014 · strength 0.04
- Zhiyu Chen · 1 shared paper, 2014 · strength 0.04
- Olivia McGinn · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.